바로가기 및 건너띄기 링크
본문 바로가기
주메뉴 바로가기

뉴스레터

home > 자료실> 뉴스레터

글자크기

Newsletter October, 2016

Newsletter October, 2016 : 작성자, 작성일, 조회수, 정보 제공
작성자 관리자
작성일 2016-11-01 조회수 2,429

Korea Pharmaceutical Industry Newsletter

      Newsletter  October, 2016  
MainNews
Teva and Celltrion Partner on Biosimilar Commercialization
Teva Pharmaceuticals and Celltrion Healthcare announced that they have entered into a partnership to commercialize two of Celltrion’s monoclonal antibody (mAb) biosimilar candidates in the United States and Canada.
LG Life Sciences wins $81M vaccine deal with UNICEF
LG Life Sciences announced on Thursday that it has secured a $81 million deal to supply its 5-in-1 multifunctional vaccine "Eupenta" to UNICEF from 2017∼2019
Boryung, Kiara health to supply 6.93M cancer treatment to Africa
Boryung Pharmaceuticals has signed an agreement with South Africa’s Kiara Health to supply cancer drugs worth US$6.93 million to 10 African countries
Daewha Pharma receives US$20M order from Novosic in UAE
Daewha Pharmaceutical reported on Oct. 12 that it has inked a US$20.12 million five-year contract with NovoSic in United Arab Emirates to supply pharmaceutical products under the condition its products are granted approval for sale in 11 countries including Saudi Arabia.
Korea Pharmaceutical company
Shin Poong Pharm.Co.,Ltd. was founded in 1962. The company is the pharmaceutical company with the No.1 sales of prescription drugs in the surgery market. Shin Poong has been successfully producing API and finished products overseas as well as in domestic market. Shin Poong Pharm. has established a number of overseas branches including China and Vietnam.
GL Rapha founded in 2001, are engaged in pharmaceutical industry, GMP consulting and overseas factory projects.. The company's business segments are Trading & Marketing, Bio R&D, Pharmaceutical manufacturing, Hospital & Health Care, and Project development & Engineering. GL Rapha is aiming at the global localization for maximizing mutually beneficial collaborations and business ventures with a strong global network.
2015 혁신형제약기업 소개책자(영문) 기업디렉토리북 포털 링크 기업디렉토리북 포털 링크 바이오의약품산업 디렉토리북(English)
Korea Pharmaceutical company license-out information
 
Products Expected to Export & Technology Transfer
 
- 40 Innovative Pharma Companies have over 300 R&D pipeline
 
pipeline
 
Green Cross YuYu Pharma Samsung Bioepis Kolmar Kolon Life Science
 
GL Rapha Ildong Kuhnil Pharm. License Deal list Korea pharm 2016
 
 
khidi mohw biokorea epharma kpma kdra kobia mfds
 

댓글등록

로그인 또는 본인확인 후 작성 가능합니다.

0/250

의견입력영역